Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling

Nature Communications

Volumn 5, Issue , 2014, Pages

  Chen, Wan Jiun ^a,b   Ho, Chao Chi ^c   Chang, Yih Leong ^a   Chen, Hsuan Yu ^b   Lin, Chih An ^a   Ling, Thai Yen ^a   Yu, Sung Liang ^a   Yuan, Shin Sheng ^b   Louisa Chen, Yu Ju ^b   Lin, Chien Yu ^b   Pan, Szu Hua ^a   Elizabeth Chou, Han Yi ^d,e   Chang, Gee Chen ^f,g   Chu, Wen Cheng ^a   Lee, Yee Ming ^a   Lee, Jen Yi ^a   Lee, Pei Jung ^a   Li, Ker Chau ^b,h   Chen, Huei Wen ^a,d   Yang, Pan Chyr ^a,c,i  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b INSTITUTE OF STATISTICAL SCIENCE   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e INSTITUTE OF CHEMISTRY   (Taiwan)

^f NATIONAL YANG MING UNIVERSITY   (Taiwan)

^g TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; ORGANIC CATION TRANSPORTER 3; SOMATOMEDIN B; SOMATOMEDIN RECEPTOR; TRANSCRIPTION FACTOR NANOG; HOMEODOMAIN PROTEIN; IGF1R PROTEIN, HUMAN; NANOG PROTEIN, HUMAN; POU5F1 PROTEIN, HUMAN; THY 1 ANTIGEN;

CANCER; PLASTICITY; SIGNALING; SURVIVAL; TUMOR;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER PATIENT; CANCER STAGING; CANCER STEM CELL; CANCER SURVIVAL; CELL DIFFERENTIATION; FIBROBLAST; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PARACRINE SIGNALING; PRIMARY CELL CULTURE; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS; TUMOR MICROENVIRONMENT; ADENOCARCINOMA; AGED; ANIMAL; CANCER TRANSPLANTATION; CELL CULTURE; FEMALE; GENE EXPRESSION PROFILING; GENETICS; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; MOUSE; SMALL CELL LUNG CANCER; SQUAMOUS CELL CARCINOMA; VERY ELDERLY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANIMALS; ANTIGENS, THY-1; CARCINOMA, SQUAMOUS CELL; CELLS, CULTURED; FEMALE; FIBROBLASTS; GENE EXPRESSION PROFILING; HOMEODOMAIN PROTEINS; HUMANS; INSULIN-LIKE GROWTH FACTOR II; LUNG NEOPLASMS; MALE; MICE; MIDDLE AGED; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; PARACRINE COMMUNICATION; RECEPTORS, SOMATOMEDIN; SMALL CELL LUNG CARCINOMA; TUMOR MICROENVIRONMENT;

EID: 84897058262     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms4472     Document Type: Article

References (68)

1. Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics, 2012. CA Cancer J. Clin. 62, 10-29 (2012).
2. Kobayashi, S. et al. EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. New Engl. J. Med. 352, 786-792 (2005).
3. Sequist, L. V., Bell, D. W., Lynch, T. J. & Haber, D. A. Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer. J. Clin. Oncol. 25, 587-595 (2007).
4. Egeblad, M., Nakasone, E. S. & Werb, Z. Tumors as organs: complex tissues that interface with the entire organism. Dev. Cell 18, 884-901 (2010).
5. Eramo, A., Haas, T. L. & De Maria, R. Lung cancer stem cells: tools and targets to fight lung cancer. Oncogene 29, 4625-4635 (2010).
6. Joyce, J. A. & Pollard, J. W. Microenvironmental regulation of metastasis. Nat. Rev. Cancer 9, 239-252 (2009).
7. Reya, T., Morrison, S. J., Clarke, M. F. & Weissman, I. L. Stem cells, cancer, and cancer stem cells. Nature 414, 105-111 (2001).
8. McCarthy, N. Microenvironment: enforced compliance. Nat. Rev. Cancer 12, 152-153 (2012).
9. Mitra, S., Stemke-Hale, K., Mills, G. B. & Claerhout, S. Interactions between tumor cells and microenvironment in breast cancer: a new opportunity for targeted therapy. Cancer Sci. 103, 400-407 (2012).
10. Vaiopoulos, A. G., Kostakis, I. D., Koutsilieris, M. & Papavassiliou, A. G. Colorectal cancer stem cells. Stem Cells 30, 363-371 (2012).
11. Malanchi, I. et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 481, 85-89 (2012).
12. Zhang, W. C. et al. Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis. Cell 148, 259-272 (2012).
13. Wang, J. C. & Dick, J. E. Cancer stem cells: lessons from leukemia. Trends Cell Biol. 15, 494-501 (2005).
14. Pardal, R., Clarke, M. F. & Morrison, S. J. Applying the principles of stem-cell biology to cancer. Nat. Rev. Cancer 3, 895-902 (2003).
15. Clevers, H. The cancer stem cell: premises, promises and challenges. Nat. Med. 17, 313-319 (2011).
16. Kim, C. F. et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121, 823-835 (2005).
17. Eramo, A. et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 15, 504-514 (2008).
18. Ho, M. M., Ng, A. V., Lam, S. & Hung, J. Y. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res. 67, 4827-4833 (2007).
19. Vermeulen, L. et al. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc. Natl Acad. Sci. USA 105, 13427-13432 (2008).
20. Sullivan, J. P. et al. Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling. Cancer Res. 70, 9937-9948 (2010).
21. Bertolini, G. et al. Highly tumorigenic lung cancer CD133 cells display stemlike features and are spared by cisplatin treatment. Proc. Natl Acad. Sci. USA 106, 16281-16286 (2009).
22. Fuchs, E., Tumbar, T. & Guasch, G. Socializing with the neighbors: stem cells and their niche. Cell 116, 769-778 (2004).
23. Sneddon, J. B. & Werb, Z. Location, location, location: the cancer stem cell niche. Cell Stem Cell 1, 607-611 (2007).
24. Ling, T. Y. et al. Identification of pulmonary Oct-4 stem/progenitor cells and demonstration of their susceptibility to SARS coronavirus (SARS-CoV) infection in vitro. Proc. Natl Acad. Sci. USA 103, 9530-9535 (2006).
25. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006).
26. Thomson, J. A. et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147 (1998).
27. Williams, R. L. et al. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336, 684-687 (1988).
28. Chaffer, C. L. et al. Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances Tumorigenicity. Cell 154, 61-74 (2013).
29. Schwitalla, S. et al. Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell 152, 25-38 (2013).
30. Ghajar, C. M. et al. The perivascular niche regulates breast tumour dormancy. Nat. Cell Biol. 15, 807-817 (2013).
31. Kalluri, R. & Zeisberg, M. Fibroblasts in cancer. Nat. Rev. Cancer 6, 392-401 (2006).
32. Kojima, Y. et al. Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts. Proc. Natl Acad. Sci. USA 107, 20009-20014 (2010).
33. Bremnes, R. M. et al. The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer. J. Thorac. Oncol. 6, 209-217 (2011).
34. Orimo, A. et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/ CXCL12 secretion. Cell 121, 335-348 (2005).
35. Albini, A. & Sporn, M. B. The tumour microenvironment as a target for chemoprevention. Nat. Rev. Cancer 7, 139-147 (2007).
36. Kalluri, R. & Weinberg, R. A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119, 1420-1428 (2009).
37. Thiery, J. P., Acloque, H., Huang, R. Y. & Nieto, M. A. Epithelial-mesenchymal transitions in development and disease. Cell 139, 871-890 (2009).
38. Barone, I. et al. Leptin mediates tumor-stromal interactions that promote the invasive growth of breast cancer cells. Cancer Res. 72, 1416-1427 (2012).
39. Giannoni, E. et al. Reciprocal activation of prostate cancer cells and cancerassociated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness. Cancer Res. 70, 6945-6956 (2010).
40. Tirino, V. et al. Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization. FASEB J. 27, 13-24 (2013).
41. Filatova, A., Acker, T. & Garvalov, B. K. The cancer stem cell niche(s): The crosstalk between glioma stem cells and their microenvironment. Biochim. Biophys. Acta 1830, 2496-2508 (2013).
42. Gangemi, R. M. et al. SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity. Stem Cells 27, 40-48 (2009).
43. Chiou, S. H. et al. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res. 70, 10433-10444 (2010).
44. Visvader, J. E. & Lindeman, G. J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 8, 755-768 (2008).
45. Magee, J. A., Piskounova, E. & Morrison, S. J. Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell 21, 283-296 (2012).
46. Chang, C. J. et al. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat. Cell Biol. 13, 317-323 (2011).
47. Mani, S. A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715 (2008).
48. Zhao, C. et al. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 458, 776-779 (2009).
49. Shan, J. et al. Nanog regulates self-renewal of cancer stem cell through IGF pathway in human hepatocellular carcinoma. Hepatology 56, 1004-1014 (2012).
50. Richards, M., Fong, C. Y., Chan, W. K., Wong, P. C. & Bongso, A. Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. Nat. Biotechnol. 20, 933-936 (2002).
51. Doedens, A. L. et al. Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression. Cancer Res. 70, 7465-7475 (2010).
52. Xu, Y., Hu, Y. D., Zhou, J. & Zhang, M. H. Establishing a lung cancer stem cell culture using autologous intratumoral fibroblasts as feeder cells. Cell Biol. Int. 35, 509-517 (2011).
53. Hanahan, D. & Coussens, L. M. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21, 309-322 (2012).
54. Mannello, F. & Tonti, G. A. Concise review: no breakthroughs for human mesenchymal and embryonic stem cell culture: conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned medium, or ad hoc formula? All that glitters is not gold! Stem Cells 25, 1603-1609 (2007).
55. Franco, O. E. et al. Altered TGF-beta signaling in a subpopulation of human stromal cells promotes prostatic carcinogenesis. Cancer Res. 71, 1272-1281 (2011).
56. Bendall, S. C. et al. IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature 448, 1015-1021 (2007).
57. Vermeulen, L., de Sousa e Melo, F., Richel, D. J. & Medema, J. P. The developing cancer stem-cell model: clinical challenges and opportunities. Lancet Oncol. 13, e83-e89 (2012).
58. Bjornson, C. R., Rietze, R. L., Reynolds, B. A., Magli, M. C. & Vescovi, A. L. Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. Science 283, 534-537 (1999).
59. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 (2007).
60. Navab, R. et al. Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer. Proc. Natl Acad. Sci. USA 108, 7160-7165 (2011).
61. Tesei, A. et al. Isolation of stem/progenitor cells from normal lung tissue of adult humans. Cell Prolif. 42, 298-308 (2009).
62. Dontu, G. et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 17, 1253-1270 (2003).
63. Ginestier, C. et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1, 555-567 (2007).
64. Goodell, M. A., Brose, K., Paradis, G., Conner, A. S. & Mulligan, R. C. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183, 1797-1806 (1996).
65. Acosta, J. C. et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133, 1006-1018 (2008).
66. Zoller, M. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat. Rev. Cancer 11, 254-267 (2011).
67. Zuo, J. et al. Novel polypyridyl chelators deplete cellular zinc and destabilize the X-linked inhibitor of apoptosis protein (XIAP) prior to induction of apoptosis in human prostate and breast cancer cells. J. Cell. Biochem. 113, 2567-2575 (2012).
68. Wielenga, V. J. et al. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am. J. Pathol. 154, 515-523 (1999).